Onconetix, Inc.
ONCO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $0 | $0 | $0 |
| % Growth | 4,217.3% | – | – | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $1 | -$1 | -$0 | -$0 |
| % Margin | 41.8% | -1,927.9% | – | – |
| R&D Expenses | $0 | $2 | $4 | $1 |
| G&A Expenses | $11 | $15 | $9 | $2 |
| SG&A Expenses | $11 | $15 | $9 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $46 | $18 | $0 | $0 |
| Operating Expenses | $58 | $35 | $13 | $3 |
| Operating Income | -$56 | -$36 | -$13 | -$3 |
| % Margin | -2,238% | -61,634.5% | – | – |
| Other Income/Exp. Net | -$3 | -$1 | $0 | $0 |
| Pre-Tax Income | -$60 | -$37 | -$13 | -$3 |
| Tax Expense | -$1 | -$0 | $0 | $0 |
| Net Income | -$59 | -$37 | -$13 | -$3 |
| % Margin | -2,325.2% | -63,986.5% | – | – |
| EPS | -1,823.25 | -87.6 | -1.09 | -0.31 |
| % Growth | -1,981.3% | -7,936.7% | -251.6% | – |
| EPS Diluted | -1,823.25 | -87.6 | -1.09 | -0.31 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$58 | -$37 | -$13 | -$3 |
| % Margin | -2,281.9% | -62,784.1% | – | – |